Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study
Authors:
- Yining HuangYHYining Huang
- Yan ChengYCYan Cheng
- Jiang WuJWJiang Wu
- Yansheng LiYLYansheng Li
- En XuEXEn Xu
- Zhen HongZHZhen Hong
- Zhengyi LiZLZhengyi Li
- Weiwei ZhangWZWeiwei Zhang
- Meiping DingMDMeiping Ding
- Xuguang GaoXGXuguang Gao
- Dongsheng FanDFDongsheng Fan
- Jinsheng ZengJZJinsheng Zeng
- 1 June 2008
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 7 (6) , 494-499
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- COMPARISON OF THE PROTECTIVE EFFECTS OF TYPE III PHOSPHODIESTERASE (PDE3) INHIBITOR (CILOSTAZOL) AND ACETYLSALICYLIC ACID ON INTESTINAL MICROCIRCULATION AFTER ISCHEMIA REPERFUSION INJURY IN MICEShock, 2006
- Cerebral Microbleeds Are Associated With Lacunar Stroke Defined Clinically and Radiologically, Independently of White Matter LesionsStroke, 2006
- Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trialThe Lancet, 2006
- Incidence and Trends of Stroke and Its Subtypes in ChinaStroke, 2006
- Risk of Hemorrhagic Stroke With Aspirin UseStroke, 2005
- Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial StenosisStroke, 2005
- Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary SyndromeCirculation, 2004
- Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialThe Lancet, 2004
- Incidence of Cerebral Hemorrhage in the Changsha CommunityCerebrovascular Diseases, 2004
- Proportion of Different Subtypes of Stroke in ChinaStroke, 2003